Health Highlights: April 12, 2022
By Robin Foster HealthDay Reporter
New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.